Literature DB >> 27417306

Genetic disorders of surfactant protein dysfunction: when to consider and how to investigate.

Atul Gupta1, Sean Lee Zheng1.   

Abstract

Genetic mutations affecting proteins required for normal surfactant protein function are a rare cause of respiratory disease. The genes identified that cause respiratory disease are surfactant protein B, surfactant protein C, ATP binding cassette number A3 and thyroid transcription factor-1. Surfactant protein dysfunction syndromes are highly variable in their onset and presentation, and are dependent on the genes involved and environmental factors. This heterogeneous group of conditions can be associated with significant morbidity and mortality. Presentation may be in a full-term neonate with acute and progressive respiratory distress with a high mortality or later in childhood or adulthood with signs and symptoms of interstitial lung disease. Genetic testing for these disorders is now available, providing a non-invasive diagnostic test. Other useful investigations include radiological imaging and lung biopsy. This review will provide an overview of the genetic and clinical features of surfactant protein dysfunction syndromes, and discuss when to suspect this diagnosis, how to investigate it and current treatment options. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Interstitial lung disease; RDS; Surfactant; Surfactant protein dysfunction; chILD

Mesh:

Substances:

Year:  2016        PMID: 27417306     DOI: 10.1136/archdischild-2012-303143

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  6 in total

Review 1.  Surfactant protein disorders in childhood interstitial lung disease.

Authors:  Jagdev Singh; Adam Jaffe; André Schultz; Hiran Selvadurai
Journal:  Eur J Pediatr       Date:  2021-04-11       Impact factor: 3.183

Review 2.  Location, function, and ontogeny of pulmonary macrophages during the steady state.

Authors:  Natalio Garbi; Bart N Lambrecht
Journal:  Pflugers Arch       Date:  2017-03-13       Impact factor: 3.657

Review 3.  Interstitial lung disease in newborns.

Authors:  Lawrence M Nogee
Journal:  Semin Fetal Neonatal Med       Date:  2017-03-28       Impact factor: 3.926

4.  Pediatric Case Report on an Interstitial Lung Disease with a Novel Mutation of SFTPC Successfully Treated with Lung Transplantation.

Authors:  Ji Soo Park; Yun Jung Choi; Young Tae Kim; Samina Park; Jong-Hee Chae; June Dong Park; Yeon Jin Cho; Woo-Sun Kim; Moon-Woo Seong; Sung-Hye Park; Dohee Kwon; Doo Hyun Chung; Dong In Suh
Journal:  J Korean Med Sci       Date:  2018-05-02       Impact factor: 2.153

5.  Case Report: Report of Two Cases of Interstitial Lung Disease Caused by Novel Compound Heterozygous Variants in the ABCA3 Gene.

Authors:  Fang Chen; Zhiwei Xie; Victor Wei Zhang; Chen Chen; Huifeng Fan; Dongwei Zhang; Wenhui Jiang; Chunli Wang; Peiqiong Wu
Journal:  Front Genet       Date:  2022-04-06       Impact factor: 4.772

Review 6.  The potential of antisense oligonucleotide therapies for inherited childhood lung diseases.

Authors:  Kelly M Martinovich; Nicole C Shaw; Anthony Kicic; André Schultz; Sue Fletcher; Steve D Wilton; Stephen M Stick
Journal:  Mol Cell Pediatr       Date:  2018-02-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.